SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004442
Filing Date
2019-05-08
Accepted
2019-05-08 16:02:38
Documents
78
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20190331x10q.htm 10-Q 2210470
2 EX-10.1 icpt-20190331ex10114c549.htm EX-10.1 170862
3 EX-10.2 icpt-20190331ex10288e628.htm EX-10.2 165416
4 EX-10.3 icpt-20190331ex103b764bf.htm EX-10.3 99610
5 EX-31.1 icpt-20190331ex3119f032d.htm EX-31.1 12874
6 EX-31.2 icpt-20190331ex312658898.htm EX-31.2 12582
7 EX-32.1 icpt-20190331ex321568279.htm EX-32.1 14581
  Complete submission text file 0001558370-19-004442.txt   7492576

Data Files

Seq Description Document Type Size
8 EX-101.INS icpt-20190331.xml EX-101.INS 1515226
9 EX-101.SCH icpt-20190331.xsd EX-101.SCH 43139
10 EX-101.CAL icpt-20190331_cal.xml EX-101.CAL 58712
11 EX-101.DEF icpt-20190331_def.xml EX-101.DEF 130832
12 EX-101.LAB icpt-20190331_lab.xml EX-101.LAB 350049
13 EX-101.PRE icpt-20190331_pre.xml EX-101.PRE 299313
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 19806570
SIC: 2834 Pharmaceutical Preparations